The PowdAir® is a simple, reusable, low cost, capsule-based inhaler developed for indications where a chronic or a medium term treatment is needed, such as Asthma, Chronic Obstructive Pulmonary Disease (COPD) and other respiratory diseases.

PowdAir is designed to be simple, easy to use and very low cost. It features an innovative plastic blade system for capsule opening and relies in only 4 components without any metal parts or complex assembly steps which allows to achieve a very low cost. PowdAir is fully injection molded and it is available for clinical trial supply and for licensing.

PowdAir Features

  • Reusable, capsule-based dry powder inhaler
  • Patented in 42 countries up to 2034
  • Four plastic components, fully injection molded
  • Operates with size #3 capsules
  • Simple, easy to use, 4 steps to inhalation: push – load – close – open – inhale
  • Small size, highly portable and convenient
  • Fully validated by three human factors studies
  • High performance, capsule becomes a highly turbulent chamber
  • Dose up to 50 mg and fine particle fraction from 40% and up to 70% achieved
  • Low flow rate dependency, performance unaffected from 35 L/min
  • Allows visual inspection of capsule after use
  • Simple 3 step assembly process
  • Low manufacturing cost